A recent study has spotlighted Sciome’s cutting-edge artificial intelligence tool, SWIFT-Active Screener, as a promising solution to one of the most time-consuming stages in systematic reviews (SRs): article screening.
Systematic reviews are a cornerstone of evidence-based research, relying on rigorous methodologies to synthesize findings from multiple studies. However, these reviews often require substantial time and human resources—especially when dealing with expansive datasets and strict inclusion criteria.
In response to these challenges, Sciome has developed SWIFT-Active Screener, an AI-powered machine learning platform designed to streamline the early screening phase of SRs. In a recent evaluation involving a large-scale review of mental health outcomes following PTSD treatment, researchers tested the tool’s performance against traditional manual screening.
The results were striking: SWIFT-Active Screener surpassed the 95% agreement benchmark typically expected between human reviewers and machine-assisted predictions, effectively identifying relevant articles at the title and abstract stage. Meanwhile, consistent with past evidence, the researchers found that the software can reduce screening time and effort by nearly 50%. Equally important, users—both novice and experienced—rated the software as highly intuitive and user-friendly.
The researchers emphasized that this level of performance demonstrates the potential of AI to enhance the speed and efficiency of systematic reviews without compromising methodological rigor. As systematic reviews continue to play a pivotal role in clinical and public health research, Sciome’s innovation signals a future where AI can meaningfully reduce workload and accelerate evidence synthesis across disciplines.
Read the full article here.
